<DOC>
	<DOC>NCT00472966</DOC>
	<brief_summary>To determine the effectiveness and safety of sequential therapy with of Tri-Luma® Cream and a series of Glycolic Acid peels in treatment of moderate to severe melasma.</brief_summary>
	<brief_title>Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma</brief_title>
	<detailed_description>To determine the efficacy and safety of sequential therapy with Fluocinolone acetonide 0.01%, Hydroquinone 4% and Tretinoin 0.05%, and a series of Glycolic Acid peels in the treatment of moderate to severe melasma.</detailed_description>
	<mesh_term>Melanosis</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<mesh_term>Glycolic acid</mesh_term>
	<mesh_term>Fluocinolone Acetonide</mesh_term>
	<mesh_term>Hydroquinone</mesh_term>
	<criteria>Subjects diagnosed with moderate to severe melasma Subjects under treatment for a dermatologic condition, which may interfere with the safe evaluation of the study combination (e.g. eczema, psoriasis, severe sundamage, dermatitis) Subjects with a diagnosis of skin cancer (BCE, SCC, Melanoma) in the areas to be treated</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>